Health Novartis projects +5% cc¹ sales CAGR through 2031 and sustained mid-single-digit growth over the long term November 19, 2026
Health Olema Oncology Presents Preclinical Data on Selective KAT6A Degraders in ER+/HER2- Breast Cancer Models at EORTC-NCI-AACR Symposium November 18, 2026
Health Nyxoah Obtains Default Decision Against Inspire Medical Systems in Unified Patent Court Case November 18, 2026
Health Medline Inc. announces pricing of secondary offering of Class A common stock November 18, 2026
Health Novartis showcases hematology momentum and continued breast cancer leadership at ASH and SABCS November 18, 2026
Health Vivos Therapeutics Reports Third Quarter 2026 Financial Results and Provides Operational Update November 17, 2026
Health Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people with polymyalgia rheumatica (PMR) November 17, 2026
Health Cytokinetics Announces Prescribing Information for MYQORZO® (aficamten) Expanded to Include Data from Phase 3 MAPLE-HCM November 16, 2026
Health Aclaris Therapeutics Announces Top Line Phase 2 Results for its Anti-TSLP Monoclonal Antibody Bosakitug (ATI-045) in Atopic Dermatitis (AD) November 16, 2026
Health Aclaris Therapeutics Initiates Phase 2b Trial of Modzatinib (ATI-2138) in Lichen Planus (LP) November 16, 2026